SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001633070-21-000032
Filing Date
2021-05-06
Accepted
2021-05-06 16:19:28
Documents
62
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q axla-20210331.htm   iXBRL 10-Q 1191568
2 EX-31.1 exhibit311q12021.htm EX-31.1 10566
3 EX-31.2 exhibit312q12021.htm EX-31.2 10437
4 EX-32.1 exhibit321q12021.htm EX-32.1 7213
10 GRAPHIC axla-20210331_g1.jpg GRAPHIC 99898
  Complete submission text file 0001633070-21-000032.txt   4832739

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axla-20210331.xsd EX-101.SCH 27966
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT axla-20210331_cal.xml EX-101.CAL 58239
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT axla-20210331_def.xml EX-101.DEF 121796
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT axla-20210331_lab.xml EX-101.LAB 414112
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axla-20210331_pre.xml EX-101.PRE 251389
11 EXTRACTED XBRL INSTANCE DOCUMENT axla-20210331_htm.xml XML 598520
Mailing Address 840 MEMORIAL DRIVE THIRD FLOOR CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE THIRD FLOOR CAMBRIDGE MA 02139 617-868-0949
Axcella Health Inc. (Filer) CIK: 0001633070 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38901 | Film No.: 21898087
SIC: 2836 Biological Products, (No Diagnostic Substances)